XML 189 R165.htm IDEA: XBRL DOCUMENT v3.26.1
Share-based payments - Additional Information (Details)
$ / shares in Units, € in Thousands, $ in Thousands
1 Months Ended 12 Months Ended
Mar. 26, 2025
shares
Apr. 05, 2023
shares
Jun. 30, 2025
shares
Apr. 30, 2025
shares
Jul. 31, 2024
shares
Oct. 31, 2023
shares
tranche
Jun. 30, 2023
EUR (€)
shares
Jun. 30, 2022
EUR (€)
shares
Dec. 31, 2021
shares
Dec. 31, 2025
EUR (€)
shares
tranche
Dec. 31, 2024
USD ($)
shares
tranche
Dec. 31, 2024
EUR (€)
shares
tranche
Dec. 31, 2023
USD ($)
shares
tranche
$ / shares
Dec. 31, 2023
EUR (€)
shares
tranche
Dec. 31, 2022
shares
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Number of other equity instruments granted in share based payment arrangement (in shares)                             2,520,000
Number of tranches for the right to exercise a sale option | tranche                   3 3 3 3 3  
Non-executive director remuneration, percentage received in cash                   50.00%          
Non-executive director remuneration, percentage received in equity                   50.00% 50.00% 50.00%      
Share-based compensation expense | €                   € 4,417   € 8,472   € 19,780  
Zegna non-executive directors                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Number of other equity instruments granted in share based payment arrangement (in shares)                   94,320 71,620,000 71,620,000 76,400 76,400  
Non-executive director remuneration, percentage received in equity                   50.00%          
Vesting period                   2 years          
2022 | Share price of at least USD 11.50                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Share price (in USD per share) | $ / shares                         $ 11.50    
Number of trading days determining share price                         20 days 20 days  
2022 | Share price of at least USD 11.50 | Zegna directors, excluding the CEO, key executives, and other employees                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Share price (in USD per share) | $ / shares                         $ 11.50    
Number of trading days determining share price                 10 days            
2022 | Share price of at least USD 12.50                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Share price (in USD per share) | $ / shares                         $ 12.50    
Number of trading days determining share price                         20 days 20 days  
2022 | Share price of at least USD 12.50 | Zegna directors, excluding the CEO, key executives, and other employees                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Share price (in USD per share) | $ / shares                         $ 12.50    
Number of trading days determining share price                 20 days            
Equity settled share based payments                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Other long-term employee benefits | $                     $ 7,500   $ 7,500    
Share-based compensation expense | €                       € 6,562      
Shares exercised (in shares)             468,450 459,086              
Options exercised | €             € 3,654 € 3,390              
Performance share units | Equity settled share based payments                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Number of other equity instruments granted in share based payment arrangement (in shares)     1,290,000               518,350 518,350      
Performance share units | Equity settled share based payments | Zegna directors, excluding the CEO, key executives, and other employees                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Number of other equity instruments granted in share based payment arrangement (in shares)   450,000                          
Performance share units | Equity settled share based payments | LTI Plan                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Number of other equity instruments granted in share based payment arrangement (in shares) 1,140,546                           1,417,150
Performance share units | Equity settled share based payments | Award with vesting tranches                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Number of other equity instruments granted in share based payment arrangement (in shares)                             600,000
Performance share units | Equity settled share based payments | Award with vesting tranches | Zegna directors, excluding the CEO, key executives, and other employees                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Number of other equity instruments granted in share based payment arrangement (in shares)                 900,000            
Performance share units | Equity settled share based payments | 2022                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Number of other equity instruments granted in share based payment arrangement (in shares)                         240,000 240,000  
Performance share units | Equity settled share based payments | 2023                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Number of other equity instruments granted in share based payment arrangement (in shares)                         360,000 360,000  
Performance share units | Equity settled share based payments | 2023 | Zegna directors, excluding the CEO, key executives, and other employees                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Number of other equity instruments granted in share based payment arrangement (in shares)                 450,000            
Restricted share units | Equity settled share based payments                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Number of other equity instruments granted in share based payment arrangement (in shares)         17,000 170,000                  
Restricted share units | Equity settled share based payments | 2022                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Number of other equity instruments granted in share based payment arrangement (in shares)           80,000                  
Number of equal installments | tranche           2                  
Restricted share units | Equity settled share based payments | 2023                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Number of other equity instruments granted in share based payment arrangement (in shares)           90,000                  
Number of equal installments | tranche           3                  
Retention restricted share units | Equity settled share based payments | LTI Plan                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Number of other equity instruments granted in share based payment arrangement (in shares)                         607,350 607,350  
Other share-based payments                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Share-based compensation expense | €                   € (1,416)   € 1,602   € 6,562  
CEO 2025-2027 PSUs                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Number of other equity instruments granted in share based payment arrangement (in shares)                   744,416 0 0 0 0  
Number of other equity instruments outstanding (in shares)                   744,416 0 0 0   0
Share-based compensation expense | €                   € 766   € 0   € 0  
CEO 2025-2027 PSUs | Equity settled share based payments                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                              
Number of other equity instruments granted in share based payment arrangement (in shares)       744,416                      
Number of other equity instruments outstanding (in shares)                     368,943 368,943